Lv1
50 积分 2024-04-23 加入
Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury
3个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
4个月前
已完结
Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Final overall survival analysis of the phase 3 CARES-310 study
4个月前
已关闭
Oxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1
5个月前
已完结
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
8个月前
已完结
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
8个月前
已完结
皖公网安备34019202002308
